Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Long-term data from the pivotal phase 3 ELARA trial showed durable efficacy with tisagenlecleucel in high-risk follicular ...

These long-term data support axicabtagene ciloleucel as a highly effective therapeutic approach for patients with relapsed or ...

The combination of loncastuximab tesirine (Zynlonta) and rituximab achieved promising response rates in patients with ...

The injectable cytotoxic drugs market is a critical segment of the global oncology and chemotherapy treatment market. Cytotoxic drugs are used primarily in the treatment of various cancers, as they ...

Life-saving interventions may lead to ovarian dysfunction—casting a shadow of uncertainty over a survivor's ability to ...

(UroToday.com) The 2024 SUO annual meeting included a session on smoking cessation, vaping, and e-cigarettes, featuring a presentation by Dr. Marc Bjurlin discussing e-cigarette use and the risk of ...